UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Decreased by Total Clarity Wealth Management Inc.

Total Clarity Wealth Management Inc. cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 16.2% in the second quarter, HoldingsChannel reports. The fund owned 1,867 shares of the healthcare conglomerate’s stock after selling 361 shares during the quarter. Total Clarity Wealth Management Inc.’s holdings in UnitedHealth Group were worth $951,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in UNH. Aveo Capital Partners LLC grew its stake in shares of UnitedHealth Group by 23.8% in the 4th quarter. Aveo Capital Partners LLC now owns 2,164 shares of the healthcare conglomerate’s stock valued at $1,139,000 after buying an additional 416 shares in the last quarter. 9258 Wealth Management LLC increased its stake in shares of UnitedHealth Group by 7.3% during the 4th quarter. 9258 Wealth Management LLC now owns 4,273 shares of the healthcare conglomerate’s stock worth $2,250,000 after purchasing an additional 290 shares during the last quarter. Gryphon Financial Partners LLC lifted its stake in shares of UnitedHealth Group by 80.9% in the 4th quarter. Gryphon Financial Partners LLC now owns 6,220 shares of the healthcare conglomerate’s stock valued at $3,275,000 after purchasing an additional 2,782 shares during the last quarter. TrinityPoint Wealth LLC increased its position in UnitedHealth Group by 102.8% during the fourth quarter. TrinityPoint Wealth LLC now owns 14,774 shares of the healthcare conglomerate’s stock worth $7,778,000 after buying an additional 7,489 shares during the last quarter. Finally, ING Groep NV acquired a new stake in UnitedHealth Group in the 4th quarter worth approximately $12,271,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 1.0 %

Shares of NYSE:UNH opened at $594.32 on Monday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $607.94. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The company’s 50-day moving average price is $569.08 and its two-hundred day moving average price is $517.70. The firm has a market cap of $548.81 billion, a P/E ratio of 36.33, a P/E/G ratio of 1.64 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same quarter last year, the business earned $6.14 earnings per share. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.41%. The ex-dividend date of this dividend is Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

UNH has been the subject of several research analyst reports. Baird R W raised UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Morgan Stanley raised their price objective on shares of UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. JPMorgan Chase & Co. raised their price target on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research report on Thursday, May 30th. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, September 9th. Finally, Wells Fargo & Company upped their price target on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Two equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average price target of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.